CN

ABOUT US

Based on ophthalmology, develop into a leader in China's healthcare industry

Relin Medicine (Relin), a member of Hong Kong's Grand Bless Investments, officially founded in 1996 with a belief of "pooling global resources to serve the healthcare industry in the Greater China Area", features its strong academic promotion and has long been the sole distributor of many pharmaceutical MNEs. With advantages in ophthalmology and otolaryngology, Relin has gradually developed into a pharmaceutical enterprise that integrates new drug introductions, registrations, R&D, MAH and specialized academic promotions.

30Years

Focus on professional field for 30 years

34

Branches

6600+

Cooperative hospitals at or above the municipal level

10Million Chinese yuan

Relin Ophthalmic Clinical Aid (Lions) Special Fund

215

Cooperate with volunteer hospitals

5000+

Helped patients with eye diseases

PRODUCTS and services

Products and Business

HYLO-COMOD<sup>®</sup> Sodium Hyaluronate Eye Drops

Ophthalmic Products

HYLO-COMOD® Sodium Hyaluronate Eye Drops

Learn more >
Zuofu<sup>®</sup> Levofloxacin Hydrochloride Ear Drops

Otorhinolaryngology Products

Zuofu® Levofloxacin Hydrochloride Ear Drops

Learn more >
Hospital Channel

Business

Hospital Channel

Learn more >
Retail Channel

Business

Retail Channel

Learn more >
Channel Management

Business

Channel Management

Learn more >
Broad Market

Business

Broad Market

Learn more >

R&D and registration

R&D and Registration

As a pharmaceutical company, the greatest value lies in:

1. Research and development of new drugs

2. Promotion and popularization of good drugs

Guided by market demand, the research and development of new drugs and the introduction of good products are taken as the core driving forces of enterprise development to address the unmet medical needs. 

Innovative Drugs

First-in-Class new drug MS-553
MAH

R&D & MAH
Import Registration

Imported Drug Registration

Partners

Pool global resources to serve China's healthcare industry

Relin Medicine focuses on specialty products that are both distinctive and competitive in the market. Currently, the company's main business area is ophthalmology, and it is actively expanding into fields such as otolaryngology. Its partners are located in various countries including China, the United States, Germany, Switzerland, Japan, South Korea, Singapore, Finland, and Italy. Relin Medicine can provide one-stop services to partners, including market research, product registration, import and commercial distribution, and sales promotion. Relin Medicine's cooperation modes are diverse and open,  ranging from a single general agent model to multiple modes such as project introduction, technology transfermation, collaborative development, and contract manufacturing.

Ursapharm
Icare
AZDA
泰俊
echo
HOYA
MingSight
科益
万和
汇恩兰德

social responsibility

Social Responsibility

Earning can change life, while giving can create life.

While continuously growing, Relin Medicine does not forget to give back to society. In 2011, Relin Medicine joined forces with the Shenzhen Lions Clubs and the Chinese Ophthalmological Society to establish the "Relin Ophthalmic Clinical Aid (Lions) Special Fund". As of now, Relin Medicine has donated a total of 10 million yuan and partnered with 215 volunteer hospitals to help patients with eye diseases who cannot afford effective medical care due to poverty.